{"id":"dfn-15-dose-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Insomnia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"DFN-15 targets the 5-HT7 receptor, a G-protein coupled receptor involved in circadian rhythm regulation and mood modulation. By antagonizing this receptor, the drug aims to restore normal sleep-wake cycles and improve mood symptoms. This mechanism is distinct from traditional antidepressants and may offer a novel approach to treating sleep and mood disorders.","oneSentence":"DFN-15 is a selective serotonin 5-HT7 receptor antagonist designed to modulate serotonergic neurotransmission.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:10:42.502Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder with sleep disturbance"}]},"trialDetails":[{"nctId":"NCT03554772","phase":"PHASE2","title":"Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2018-06-19","conditions":"Acute Pain","enrollment":120},{"nctId":"NCT03051685","phase":"PHASE1","title":"Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2015-07-20","conditions":"Healthy","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Celecoxib"],"phase":"phase_2","status":"active","brandName":"DFN-15 Dose 1","genericName":"DFN-15 Dose 1","companyName":"Dr. Reddy's Laboratories Limited","companyId":"dr-reddy-s-laboratories-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DFN-15 is a selective serotonin 5-HT7 receptor antagonist designed to modulate serotonergic neurotransmission. Used for Major depressive disorder with sleep disturbance.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":3,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}